Twice-Daily Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination: Lung Function Improvements In The Augment COPD Trial In Patients With Moderate To Severe COPD

被引：0
|
作者：
D'Urzo, A. D. [1 ]
Rennard, S. I. [2 ]
Kerwin, E. M. [3 ]
Mergel, V. [4 ]
Leselbaum, A. [5 ]
Caracta, C. [4 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Nebraska Med Ctr, Omaha, NE USA
[3] Clin Res Inst, Medford, OR USA
[4] Forest Res Inst, Jersey City, NJ USA
[5] Almirall SA, Barcelona, Spain
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3776
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effect of aclidinium bromide/formoterol fumarate fixed-dose combination (FDC) on night-time and early morning symptoms in COPD
    Singh, Dave
    Chapman, Kenneth
    Make, Barry
    Mocarski, Michelle
    Serra, Cristina
    Gil, Esther Garcia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [22] Improvements In Quality Of Life And Dyspnea In COPD Patients With Twice-Daily Aclidinium
    Gelb, A. F.
    Donohue, J. F.
    D'Urzo, A.
    Rekeda, L.
    Jarreta, D.
    Lateiner, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [23] Twice-daily aclidinium bromide in COPD patients: A pooled analysis of lung function in the ACCORD-COPD I and ATTAIN trials
    Kerwin, Edward
    Jones, Paul
    D'Urzo, Anthony
    Rekeda, Ludmyla
    Gil, Esther Garcia
    Caracta, Cynthia
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [24] Lung function with aclidinium/formoterol fixed-dose combination: Pooled analysis of two phase III studies in COPD
    Singh, Dave
    D'Urzo, Anthony D.
    Donohue, James F.
    Chuecos, Ferran
    Leselbaum, Anne
    Garcia Gil, Esther
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [25] Efficacy of aclidinium/formoterol fixed-dose combination versus salmeterol/fluticasone in COPD
    Vogelmeier, Claus
    Paggiaro, Pier Luigi
    Dorca, Jordi
    Sliwinski, Pawel
    Mallet, Marcel
    Kirsten, Anne-Marie
    Seoane, Beatriz
    Maria Segarra, Rosa
    Leselbaum, Anne
    Garcia Gil, Esther
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [26] Efficacy Of Twice-Daily Aclidinium Bromide 400 μg In Subgroups Of Patients With COPD
    Kerwin, E. M.
    Jones, P. W.
    D'Urzo, A. D.
    Bateman, E. D.
    Lamarca, R.
    Garcia Gil, E.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [27] Efficacy and tolerability of aclidinium bromide/fomoterol fumarate fixed-dose combination in patients with COPD: A 1-year study
    Make, Barry
    Donohue, James
    Soong, Weily
    Zhong, Xiaoyun
    Leselbaum, Anne
    Caracta, Cynthia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [28] Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study
    Jones, Paul W.
    Singh, Dave
    Bateman, Eric D.
    Agusti, Alvar
    Lamarca, Rosa
    de Miguel, Gonzalo
    Segarra, Rosa
    Caracta, Cynthia
    Gil, Esther Garcia
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (04) : 830 - 836
  • [29] Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
    Anthony D D’Urzo
    Stephen I Rennard
    Edward M Kerwin
    Victor Mergel
    Anne R Leselbaum
    Cynthia F Caracta
    Respiratory Research, 15
  • [30] Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
    D'Urzo, Anthony D.
    Rennard, Stephen I.
    Kerwin, Edward M.
    Mergel, Victor
    Leselbaum, Anne R.
    Caracta, Cynthia F.
    RESPIRATORY RESEARCH, 2014, 15
12345